The 17th Annual Meeting of ISMPP will be held virtually on April 12-14, 2021: register now!
A recent survey assessed the prevalence of editors altering peer review reports. Read about the results here.
Medical research without adequate pre-publication review could damage public trust in medical science
Recommendations from 3 leading medical communication organisations aim to protect the integrity of published scientific and medical research.
Acceleration of research and implications for research transparency: our summary of the third Biomedical Transparency Summit series webinar
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
Find out more about Springer Nature’s latest open access publishing options – and the concerns that some have raised.
Find out more about EMWA’s dedicated issue on writing for patients, covering publication planning through to social media.
Open access across the globe: our summary of the second Biomedical Transparency Summit series webinar
Find out more about what was covered during the second 2021 webinar from the Center for Biomedical Research Transparency.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Find out more about the case for open access presented by Open Pharma.
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.
Research integrity across the Atlantic: our summary of the first Biomedical Transparency Summit series webinar
Find out more about what was covered during the first 2021 webinar from the Center for Biomedical Research Transparency.
Find out how principles of research integrity can be put into practice to combat fraud and misconduct.
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
Overcoming barriers to reporting negative data: perspectives from the Center for Biomedical Research Transparency’s founder
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
Find out more about what this resource has to offer.
Professor Marcus Munafò discusses the importance of reproducibility in scientific research and how we can overcome barriers to achieving it.